Develops specialty chemicals for personal care and industrial markets.
Jun 2026Revenue $1.84B/yrExpenses $1.71B/yr
No trend
Figures by year
Is Innospec profitable?
Yes. In the 12 months to Jun 2026, revenue was $1.84B and expenses $1.71B.
| Fiscal year to | Revenue | Expenses | Operating profit |
|---|---|---|---|
| Dec 2025 | $1.78B | $1.65B | $130M |
| Dec 2024 | $1.85B | $1.67B | $178M |
| Dec 2023 | $1.95B | $1.79B | $162M |
| Dec 2022 | $1.96B | $1.78B | $187M |
| Dec 2021 | $1.48B | $1.35B | $132M |
| Dec 2020 | $1.19B | $1.16B | $33.7M |
| Dec 2019 | $1.51B | $1.36B | $150M |
| Dec 2018 | $1.48B | $1.34B | $134M |
| Dec 2017 | $1.31B | $1.18B | $125M |
| Dec 2016 | $883M | $785M | $98.2M |
When the cash runs out, on the chart. A red line at the date the company’s cash would run out at its latest burn, so you can see whether it gets to break-even first. Part of a subscription.